Available online on 15.02.2023 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2023 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Research Article
Assessment of the Physico-Chemical Conformity of an Antiseptic Solution: Case of Polyvidone - Iodine 10%
CISSE Mody 1,3,4 , BADIAGA Mamadou2, 4, DEMBELE Ousmane1,3 , OUATTARA K. Ibrahim1 , SANGARE Coumba Dite Astan2 , COULIBALY S. Moussa1 , SANGARE Modibo3 , TRAORE Nah4 , KOUMARE Y. Bénoit1, 3
1 National Health Laboratory of Bamako. BP: E 4559
2 Institute of Applied Sciences of the University of Technical Sciences and Technologies of Bamako. BP E 3206
3 Faculty of Pharmacy of the University of Technical Sciences and Technologies of Bamako. BP 1805
4 Laboratory of Organic Chemistry and Natural Substances, Faculty of Science and Technology of the University of Technical Sciences and Technologies of Bamako. BP E 3206
|
Article Info: _______________________________________________ Article History: Received 30 Nov 2022 Reviewed 07 Jan 2023 Accepted 18 Jan 2023 Published 15 Feb 2023 _______________________________________________ Cite this article as: Cisse M , Badiaga M, Dembele O, Ouattara KI, Sangare CDA, Coulibaly SM, Sangare M, Traore N, Koumare YB, Assessment of the Physico-Chemical Conformity of an Antiseptic Solution: Case of Polyvidone - Iodine 10%, Journal of Drug Delivery and Therapeutics. 2023; 13(2):32-36 DOI: http://dx.doi.org/10.22270/jddt.v13i2.5734 _______________________________________________*Address for Correspondence: Dr Mody Cisse, Faculty of Pharmacy, USTTB, Bamako, Mali |
Abstract ___________________________________________________________________________________________________________________ Introduction: Antiseptics have been used for many years in human and veterinary medicine. Over the years, the lengthening of surgical procedures in human surgery and the increasingly frequent use of inert material has increased the risk of infections. This was why skin antisepsis has become very important in the prevention of infections of the surgical wound and resulting complications. In Mali, at the Gabriel Touré University Hospital, the most prescribed family of antiseptics was the halogenated ones, in particular 10% povidone iodine for wound and surgical site antisepsis. This study was aimed to control the quality of 10% povidone iodine used in the hospital. Methodology: We conducted at the Medicines Quality Control Service of the National Health Laboratory of Mali (LNS) a retrospective analytical study on the quality control of 10% povidone iodine. We obtained 10% povidone iodine samples from the Pharmacie Populaire du Mali (PPM). We analyzed 48 batches of samples in regards of visual inspection, average volume, titrimetry, colorimetric test and pH control. Results: All 48 analyzed batches were compliant, i.e. contained the active ingredient and could be used in health facilities or at home as an antiseptic. Conclusion: All analyzed batches of 10% povidone iodine samples did not show any cases of inconsistency and therefore could be used in the management of wound dressings. Future Direction: Use other analytical methods like HPLC to test the quality control of povidone and other types of antiseptics. Keywords: antiseptic, povidone-iodine 10%, compliance, quality control |
Historically, the fight against infectious diseases has held an important place. Long before the word antiseptic was used, many substances were used to avoid the risk of contamination1. An antiseptic is a product intended to destroy micro-organisms present on living tissues (healthy skin, mucous membranes, wounds) used under defined conditions2. Povidone-Iodine is an antiseptic whose active ingredient is based on iodine, intended to be applied to the skin.
It contains 80–120% of the amount of iodine labeled on the bottle and may contain a small amount of alcohol3. The application of povidone iodine has very quickly been extended to various fields, in particular in several products of our daily life. As a result, the question of its safety in humans has been raised, as well as the risks of allergy associated with the use of povidone iodine4. In the strategy of asepsis, antiseptics and disinfectants retain a prominent place despite the advent of antibiotics in medicine, particularly in surgery, has led to a revolution in therapy, somewhat masking the interest of antiseptics5.
Known under the name of BETADINE®, it is used in the surgical field, for the antisepsis of the skin, wounds, minor superficial burns and as adjunctive treatment of infections of the skin and mucous membranes. It is a yellow to brown aqueous solution with an alcoholic odor. The quality of this molecule is important because its non-compliance could eitherlead to infections (case of use of the product after its expiration date) and/or lengthen the duration of treatment (case of sub dosage). In SINGAPORE, tests have demonstrated the strong in vitro virucidal activity of BETADINE®, which eliminated 99.99% of SARS-cov-2 viral particles in 30 seconds. The products subjected to this test were BETADINE® antiseptic products based on Povidone Iodine (PVP-I), in particular in solution (10% PVP-I)6.
Antiseptics including povidone iodine act locally by denaturing proteins, blocking metabolism or by altering the membranes of micro-organisms. Correct prescription and application of constantly monitored antiseptics can improve both the quantitative and qualitative management of the surgery patients5. CAMARA Issaka has reported in 2005 that povidone iodine has represented 20% of non-compliant drugs in all of the drugs received from the PPM7. We initiated this retrospective study to evaluate the physico-chemical conformity of the Povidone-Iodine solution received at the Quality Control Service of Medicines of the National Laboratory of health.
We carried out a retrospective study at the Medicines Quality Control Department from September 28 to December 28, 2020, i.e. three months to analyze the conformity of polyvidones iodines.
We used glassware, a midon, 1N and 0.1 M hydrochloric acid, powdered sodium thiosulfate and 0.02 M, powdered sodium carbonate, Mettler toledo brand pH meter, and 1EL- automatic titrator 18-440.
The samples analyzed came from the Pharmacie Populaire du Mali in Bamako. There were forty-eight (48) batches of five (5) bottles of Povidone Iodine 10%, W/V, received between May and June 2020. We followed the protocol approved by the British Pharmacopoeia (BP), 2019 volume Ⅲ, 85 to analyze our samples,
The various analyzes focused on:
It consisted in carrying out an organoleptic examination of the samples through sight, touch and smell to ensure that they meet the determined quality specifications.
It allowed us to check if the quantity (mL) marked on the packaging is the same as the capacity in the bottle. The capacity is poured into a 500 mL graduated cylinder. It is carried out to control the quantity decreed by the manufacturer if it fulfilled the average volume marked on the packaging 3.
It was performed on the samples to determine the acidity, alkalinity or neutrality of an aqueous solution.
The Colorimetric Test identified the active ingredient in the samples. Our case was the identification of iodine.
Average volume Vm = The average volume makes it possible to check whether the quantity (mL) marked on the packaging is the same as the capacity in the bottle. The capacity was poured into a 500 mL graduated cylinder. It was carried out to control the quantity decreed by the manufacturer if it met the average volume marked on the packaging3.
Vm
N/B: n= number of vials and Vm= average volume
Titration is a chemical method which makes it possible to control the quantity of the active principle present in a solution. In our case, each mL of 0.02 M sodium thiosulfate was equivalent to 2.538 mg of iodine, the standard was given in the protocol.
2H+ + 2IO 3 -+ 5HSO 3 - → I2 + 5HSO - 4 + H 2 O
+ 2I- → I2 + 2Cl-
Figure 1: Oxidation/reduction equation by titration with sodium thiosulfate.
The results obtained are recorded in the tables below.
The analysis of the different vials made it possible to have results distributed in Table I.
Table I: Determination of visual and organoleptic inspection of samples
|
Designations |
Attendance |
|
Product Name |
Povidone-Iodine |
|
Name and amount of active ingredient |
Povidone-Iodine 10% W/V |
|
Expiration date/ Date of manufacture |
Yes |
|
Manufacturer's name and address |
Yes |
|
Aspect |
Plastic yellow bottle |
|
Solution color |
brown yellow |
|
Smell |
alcoholic |
The visual and organoleptic examinations met the standards of good manufacturing practice (GMP) (Table I). All batches of samples were all compliant, our results were similar to those obtained by BARBACHE Roumeila, et al, 20209 and CHABLA Younes et al, 201810 in Algeria. They have all reported that all the information was mentioned on either the packaging or the bottle.
The values obtained from the batches are recorded in Table II.
This was to check the marked amount of PVI on the package. Povidone Iodine has an acid pH, it was a matter of determining the pH for the 48 batches to be analyzed.
Table II: Distribution of the average volume and the pH according to the batch number of povidone10%.
|
Batch number |
Average volume ( (mL ) |
pH value |
|
200425 |
207.5 |
4.37 |
|
200426 |
207.5 |
4.70 |
|
200427 |
207.5 |
4.56 |
|
200428 |
207.5 |
4.70 |
|
200429 |
207.5 |
4.35 |
|
200430 |
207.5 |
4.42 |
|
200431 |
207.5 |
4.14 |
|
200432 |
210 |
4.59 |
|
200633 |
210 |
4.325 |
|
200634 |
210 |
4,254 |
|
200635 |
210 |
4,305 |
|
200636 |
210 |
4,316 |
|
200637 |
210 |
4,107 |
|
200638 |
210 |
4,515 |
|
200639 |
210 |
4,269 |
|
200640 |
207.5 |
4,318 |
|
200641 |
207.5 |
4,137 |
|
200642 |
210 |
4,236 |
|
200643 |
207.5 |
4,055 |
|
200644 |
207.5 |
4,316 |
|
200645 |
207.5 |
4,070 |
|
200646 |
207.5 |
4,062 |
|
200647 |
207.5 |
4,514 |
|
200648 |
207.5 |
4,167 |
|
200425 |
207.5 |
4.37 |
|
200426 |
207.5 |
4.70 |
|
200427 |
207.5 |
4.56 |
|
200428 |
207.5 |
4.70 |
|
200429 |
207.5 |
4.35 |
|
200430 |
207.5 |
4.42 |
|
200431 |
207.5 |
4.14 |
|
200432 |
210 |
4.59 |
|
200633 |
210 |
4.325 |
|
200634 |
210 |
4,254 |
|
200635 |
210 |
4,305 |
|
200636 |
210 |
4,316 |
|
200637 |
210 |
4,107 |
|
200638 |
210 |
4,515 |
|
200639 |
210 |
4,269 |
|
200640 |
207.5 |
4,318 |
|
200641 |
207.5 |
4,137 |
|
200642 |
210 |
4,236 |
|
200643 |
207.5 |
4,055 |
|
200644 |
207.5 |
4,316 |
|
200645 |
207.5 |
4,070 |
|
200646 |
207.5 |
4,062 |
|
200647 |
207.5 |
4,514 |
|
200648 |
207.5 |
4,167 |
The determination of the average volume (Vm) showed that all the analyzed batches of samples corresponded to the quantity indicated on the packaging (200 mL) in compliance with the 2019 British Pharmacopoeia.
The pH analysis of different batches of samples showed that they were all compliant. The pH values obtained ranged from 3 to 6.5, therefore meeting the standards required by the 2019 British Pharmacopoeia. Our results were similar to those of a study carried out by ARBACHE Roumeila, et al, 2020 9 on the physico-chemical control of antiseptic preparations, showed that three batches of povidone iodine were compliant with the pH requirement. It seemed that the pH of antiseptics was variable depending on the active ingredient and the excipients that went into its formulation. According to the study carried out by CHABLA Younes, et al; 2018 of a solution of Dakin's antiseptic have reported that the pH of these batches of dakin was basic and between 8.61 and 10.9810.
Table III shows the different percentages of iodine contained in each vial. This determination will highlight the amount of iodine (or active ingredient) present in each vial of analyzed batches.
Table III: Determination of percentage of iodine according to batches analyzed
|
Batch number |
Iodine percentage (%) |
|
20041 |
1.11 |
|
20042 |
1.1002 |
|
20043 |
1.08 |
|
20044 |
1.03 |
|
20045 |
1.012 |
|
20046 |
1.05 |
|
20047 |
1.10 |
|
20048 |
1.10 |
|
20049 |
1.07 |
|
200410 |
1.04 |
|
200411 |
1.01 |
|
200412 |
1.05 |
|
200413 |
1.00 |
|
200414 |
1.05 |
|
200415 |
1.07 |
|
200416 |
1.05 |
|
200417 |
1.06 |
|
200418 |
1.05 |
|
200419 |
1.04 |
|
200420 |
1.02 |
|
200421 |
1.04 |
|
200422 |
1.11 |
|
200423 |
1.06 |
|
200424 |
0.98 |
|
200425 |
0.99 |
|
200426 |
0.94 |
|
200427 |
0.99 |
|
200428 |
0.97 |
|
200429 |
0.96 |
|
200430 |
1.05 |
|
200431 |
1.01 |
|
200432 |
1.01 |
|
200633 |
1,058 |
|
200634 |
1,073 |
|
200635 |
1,106 |
|
200636 |
1,101 |
|
200637 |
1.027 |
|
200638 |
1,022 |
|
200639 |
1,121 |
|
200640 |
1,053 |
|
200641 |
1.015 |
|
200642 |
1,081 |
|
200643 |
1,068 |
|
200644 |
1.109 |
|
200645 |
1,109 |
|
200646 |
1,053 |
|
200647 |
1,121 |
|
200648 |
1,078 |
Observation of Table III shows us that all the samples met the standards laid down by the 2019 British Pharmacopoeia. In each 100 mL solution of Povidone-Iodine, a value of between 0.85 and 1.20% Iodine was required. ARBACHE Roumeila, et al , 20209 on the physico-chemical control of antiseptic preparations, showed the iodine content was close to 1.07%. They have reported that two (2) batches were compliant, one (1) batch was overdosed and the three (3) others were under dosed.
According to the pharmacopoeia, the presence of iodine as an active ingredient is characterized by a dark blue color at the color change. All our batches of povidones tested by colorimetry were compliant with the appearance of a deep blue color, which confirmed the presence of iodine as an active ingredient.
|
Before adding starch
|
|
After adding starch |
Figure 2: Color change with the addition of water in the presence of starch as a color indicator (photo LNS, 2021).
The quality of antiseptics was of utmost importance because a poor quality antiseptic is ineffective even if used correctly and regularly. All our sample batches of iodinated povidones analyzed at the SCQM of the LNS complied with the various analytical processes that we carried out (visual inspection, average volume, titrimetry, colorimetric test, pH).
The objective of our study was to evaluate the physico-chemical quality of Povidone-Iodine 10% W/V used in sanitary environments in Mali. All 48 samples of Povidone-Iodine received and analyzed were suitable for use in surgical operations and in dressings. All values obtained met the standards according to the 2019 British Pharmacopoeia. In the future, we will carry out more in-depth studies to better clarify or explain the quality of Povidone-Iodine 10%.
Acknowledgments:
To Professor KOUMARE Y. Benoit, the director general of the LNS, the reading committee and the scientific committee of the LNS, the financing is personal because it is me who must pay the costs of this article, i.e. CISSE Mody
Conflicts of Interest: None, it was within the framework of public health and for the well-being of the Malian population
REFERENCES
[1] CCLIN Paris- Nord, Centre de Coordination de la Lutte contre les Infections Nosocomiales de l'Interrégion Paris – Nord, les antiseptiques et les désinfectants, Institut Biomédical des Cordeliers, 15 rue de l'Ecole de Médecine (esc. J - 2ème étage) - 75006 Paris (M° Odéon), (Ile-de-France, Haute-Normandie, Nord-Pas-de-Calais, Picardie) 2000; 87:2000.
[2] BECLIN E, utilisation des antiseptiques en EMS (établissement médicaux de santé, centre hospitalier de bethune,8ème journée de formation et d’information de prévention sur le risque infectieux en EMS, 24 P, 2016.
[3] USP, Pharmacopée Américaine, polyvidone iodée solution, 2019.
[4] DEFARGE J, Découverte et Utilisations de la Polyvidone ; Université de POITIERS ; Faculté de Médicine et de Pharmacie ; thèse pharmacie ; 129P, 2016.
[5] FONGORO B, évaluation de la prescription et l’utilisation des antiseptiques dans le service de chirurgie pédiatrique du C.H.U GABRIEL TOURE, Faculté de Médicine, de Pharmacie et d’Odonto-stomatologie, Thèse Pharmacie ,105P, 2000.
[6] Mundipharma, les études en laboratoire confirment l’efficacité des produits antiseptiques Betadine contre le virus Covid-19, Infectious Disease and Therapy Journal SINGAPOUR, 9 juillet 2020.
[7] CAMARA I, Etude de la qualité des médicaments génériques DCI achetés par la Pharmacie Populaire du Mali dans le cadre des appels d’offres de 2002 à 2005, Faculté de Médicine, de Pharmacie et d’Odonto-stomatologie de Bamako, Thèse de Pharmacie, 99P, 2008.
[8] Contrôle de qualité de Polyvidone Iodée, www.Wikipedia.org , consulté le 07 /11/2022 ,16H45mn
[9] BARBACHE R; LALAOUNA AED, Contrôle physico-chimique des préparations antiseptiques, CHU « Saadna Mohamed Abdennour » Sétif, 1ere journée nationale de pharmacie hospitaliere, Laboratoire de chimie analytique, département de pharmacie, Faculté de médecine, Université Saleh Boubnider, 2020, Constantine 3.
[10] CHABLA Y, DAHOUS O, LAGUEL S, , Contrôle Q d’un antiseptique de fabrication locale étude de cas : solution de dakin, Université Mouloud Mammeri faculté de médecine tizi ouzou Département de Pharmacie, 2018; p128.